Icon
+91 94997 68112
Login Register

Banzel - (200, 400 mg; Tablet, Oral)

RUFINAMIDE EISAI INC
200, 400 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
More Than 5
Less Than 5
Less Than 5
More Than 5
More Than 5
Used to prevent or control seizures (epilepsy) associated with Lennox-Gastaut syndrome (LGS).
Yes
********, ******, ******, ***** *** ***** *** *** ***** ** **** **** ** **** ******* '*** (*** **, ****), '*** (***** **, ****), '*** (*** *, ****) *** **** ************ *********. ******* **** ****** **** ***** **** ** **** *** **** ******* *** *** *********. ********** ** ********* **** *** *** **** ** ****** ***** *** ***** ** ********* *** ***** **** *** ********. ********* ** *** ********** ******** *** ****** *** ******* ** *** **, ****. ** ****** *** *** ***** **** **** **** **** ****** ** **** **** ** ********. **** ****** **** ****** * ****** ***** *** **** *.*. *** **, ****.
Banzel Patent 1 Patent 2 Patent 3
******** ******* ******* *******
****** ******* ******* *******
****** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******** *** \ *** *** **, **** ******* ******** ******** ** *** **, ****
****** *** \ *** *** **, **** ******* ******** ******** ** *** **, ****
****** *** \ *** *** **, **** ******* ******** ******** ** *** **, ****
  1. *** **, **** : ********, ******, ******, ***** *** ***** ******** ***** ***** *** **** ** **** ******* '*** (*** **, ****), '*** (***** **, ****), '*** (*** *, ****)
  2. *** **, **** : ***** ***** * **** ******* ********, ******, ******, ***** *** ***** ** ******** ***** ** ********.
  3. *** **, **** : *****, ******, ******** ******** ********* ********.
  4. *** **, **** : ********** *** ******* **** ******** ********* ** *** ***** ** ***** ******** *** ****** *** ******* ** *** **, ****.
  5. *** *, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** ***** *** ** ****** ** ** ** **** ** ********.
  6. *** **, **** : ********** *** ********* **** ******, *****, ***** ***** *** ***** ** ********* *** *** ***** *** ** ****** ** ** ** ******* ** ********.
  7. *** **, **** : ***** ***** * **** ******* **** ****** ** **** ****** ***** **** ** **** ******* '*** (*** **, ****), '*** (***** **, ****), '*** (*** *, ****).
  8. *** **, **** : ********* ******** ***** ***** *** **** ** ****** **** ****** '*** (*** **, ****)
  9. *** **, **** : ********** ********* **** **** ****** *** ******* '*** (*** **, ****), '*** (***** **, ****), '*** (*** *, ****).
  10. *** *, **** : ***** **** ********* **** ************ ** ****** '*** (*** **, ****)
  11. *** **, **** : ***** *** ********* ******* *********** ** ******* *****.
  12. *** **, **** : ********* ******** ********* ******** *** **** *** *** *** *********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.